Product Name

  • Name

    Iminodibenzyl

  • EINECS 207-787-1
  • CAS No. 494-19-9
  • Article Data34
  • CAS DataBase
  • Density 1.085 g/cm3
  • Solubility
  • Melting Point 105-108 °C(lit.)
  • Formula C14H13N
  • Boiling Point 327.7 °C at 760 mmHg
  • Molecular Weight 195.264
  • Flash Point 161.3 °C
  • Transport Information
  • Appearance Yellowish to beige crystalline powder
  • Safety 22-24/25-39-26-36/37/39-27
  • Risk Codes 36-36/37/38
  • Molecular Structure Molecular Structure of 494-19-9 (Iminodibenzyl)
  • Hazard Symbols IrritantXi
  • Synonyms 10,11-Dihydro-5H-dibenz[b,f]azepine;10,11-Dihydro-5H-dibenzo[b,f]azepine;10,11-Dihydrodibenz[b,f]azepine;2,2'-Iminobibenzyl;2,2'-Iminodibenzyl;Iminobibenzyl;NSC 72110;
  • PSA 12.03000
  • LogP 3.66680

Synthetic route

5-acetyliminodibenzyl
13080-75-6

5-acetyliminodibenzyl

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With triethyl borane; sodium hydroxide In tert-butyl methyl ether at 80℃; for 6h; Inert atmosphere; Sealed tube;99%
Stage #1: 5-acetyliminodibenzyl With Triethoxysilane; sodium triethylborohydride In tert-butyl methyl ether at 80℃; for 6h;
Stage #2: With hydrogenchloride In tert-butyl methyl ether; water at 20℃; for 1h; chemoselective reaction;
99%
Multi-step reaction with 2 steps
1: potassium hydroxide; triethyl borane / tetrahydrofuran / 24 h / 25 °C / Inert atmosphere; Schlenk technique; Sealed tube
2: sodium hydroxide; water / tetrahydrofuran / 1 h / 25 °C / Inert atmosphere; Schlenk technique; Sealed tube
View Scheme
5-propionyl-10,11-dihydro-5H-dibenzo[b,f]azepine
40583-89-9

5-propionyl-10,11-dihydro-5H-dibenzo[b,f]azepine

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With triethyl borane; sodium hydroxide In tert-butyl methyl ether at 80℃; for 6h; Inert atmosphere; Sealed tube;99%
Stage #1: 5-propionyl-10,11-dihydro-5H-dibenzo[b,f]azepine With Triethoxysilane; sodium triethylborohydride In tert-butyl methyl ether at 80℃; for 6h;
Stage #2: With hydrogenchloride In tert-butyl methyl ether; water at 20℃; for 1h; chemoselective reaction;
81%
Multi-step reaction with 2 steps
1: potassium hydroxide; triethyl borane / tetrahydrofuran / 24 h / 100 °C / Inert atmosphere; Schlenk technique; Sealed tube
2: sodium hydroxide; water / tetrahydrofuran / 1 h / 25 °C / Inert atmosphere; Schlenk technique; Sealed tube
View Scheme
dibenzoazepine
256-96-2

dibenzoazepine

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With [Fe3(1,1,1,3,3,3-hexamethyldisilazan-2-ide)4]Fe(η6-toluene); hydrogen at 20℃; under 1425.14 Torr; for 3h; Inert atmosphere; Glovebox; chemoselective reaction;92%
With tetraethylammonium perchlorate; ammonium chloride In water; N,N-dimethyl-formamide cathodic (Hg, -2.0 V vs. SCE) reduction;82%
dibenzoazepine
256-96-2

dibenzoazepine

A

9-methyl-acridine
611-64-3

9-methyl-acridine

B

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With iodine; hypophosphorous acid In acetic acid for 24h; Heating;A 92%
B 8%
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
In acetonitrile electrolysis (Et4NClO4, Hg-dropelectrode);90%
10,11-dihydro-dibenzo[b,f]azepine-5-carboxylic acid prop-2-ynyl ester

10,11-dihydro-dibenzo[b,f]azepine-5-carboxylic acid prop-2-ynyl ester

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With benzyltriethylammonium tetrathiomolybdate In acetonitrile at 25℃; for 0.75h; sonicated;88%
C18H19NO

C18H19NO

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
Stage #1: C18H19NO With Triethoxysilane; sodium triethylborohydride In tert-butyl methyl ether at 80℃; for 6h;
Stage #2: With hydrogenchloride In tert-butyl methyl ether; water at 20℃; for 1h; chemoselective reaction;
87%
With triethyl borane; sodium hydroxide In tert-butyl methyl ether at 80℃; for 6h; Inert atmosphere; Sealed tube;86%
Multi-step reaction with 2 steps
1: potassium hydroxide; triethyl borane / tetrahydrofuran / 24 h / 100 °C / Inert atmosphere; Schlenk technique; Sealed tube
2: sodium hydroxide; water / tetrahydrofuran / 1 h / 25 °C / Inert atmosphere; Schlenk technique; Sealed tube
View Scheme
C14H13Br2N

C14H13Br2N

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With C55H46N4O4W; potassium carbonate; N-ethyl-N,N-diisopropylamine In acetonitrile for 12h; Inert atmosphere; Irradiation;68%
C21H25NO

C21H25NO

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With triethyl borane; sodium hydroxide In tert-butyl methyl ether at 80℃; for 6h; Inert atmosphere; Sealed tube;67%
Stage #1: C21H25NO With Triethoxysilane; sodium triethylborohydride In tert-butyl methyl ether at 80℃; for 6h;
Stage #2: With hydrogenchloride In tert-butyl methyl ether; water at 20℃; for 1h; chemoselective reaction;
62%
Multi-step reaction with 2 steps
1: potassium hydroxide; triethyl borane / tetrahydrofuran / 24 h / 100 °C / Inert atmosphere; Schlenk technique; Sealed tube
2: sodium hydroxide; water / tetrahydrofuran / 1 h / 25 °C / Inert atmosphere; Schlenk technique; Sealed tube
View Scheme
5-acetyliminodibenzyl
13080-75-6

5-acetyliminodibenzyl

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

11-ethyliminodibenzyl
40583-88-8

11-ethyliminodibenzyl

C

ethanol
64-17-5

ethanol

Conditions
ConditionsYield
With Mo2((1)-H)2(OtBu)6; diphenylsilane In toluene for 25h; Reagent/catalyst; Solvent; Inert atmosphere; Schlenk technique; Reflux;A 62%
B 36%
C n/a
sodium cyanide
773837-37-9

sodium cyanide

impramine
50-49-7

impramine

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

2-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-(methyl)amino)acetonitrile

2-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-(methyl)amino)acetonitrile

C

2-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-4-(dimethylamino)butanenitrile

2-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-4-(dimethylamino)butanenitrile

Conditions
ConditionsYield
With [4,4’-bis(1,1-dimethylethyl)-2,2’-bipyridine-N1,N1‘]bis [3,5-difluoro-2-[5-(trifluoromethyl)-2-pyridinyl-N]phenyl-C]iridium(III) hexafluorophosphate; acetic acid In acetonitrile at 20℃; for 24h; Irradiation; Sealed tube;A 50%
B 22%
C 23%
dibenzoazepine
256-96-2

dibenzoazepine

acetic acid
64-19-7

acetic acid

A

9-methyl-acridine
611-64-3

9-methyl-acridine

B

5-acetyliminodibenzyl
13080-75-6

5-acetyliminodibenzyl

C

9-methyl-9,10-dihydroacridine
4217-52-1

9-methyl-9,10-dihydroacridine

D

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With iodine; hypophosphorous acid for 96h; Heating;A 18%
B 9%
C 20%
D 47%
2-bromophenylacetyl chloride
55116-09-1

2-bromophenylacetyl chloride

aniline
62-53-3

aniline

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
Stage #1: aniline With copper(l) iodide; n-butyllithium; tetraethylammonium bromide; triethylamine In tetrahydrofuran at -50℃; for 4h; Inert atmosphere;
Stage #2: 2-bromophenylacetyl chloride In tetrahydrofuran at 70℃; for 5h; Inert atmosphere;
45.7%
1-nitro-2-phenethylbenzene
6796-01-6

1-nitro-2-phenethylbenzene

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With trifluoroacetic acid; zinc45%
potassium cyanide

potassium cyanide

impramine
50-49-7

impramine

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

2-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-(methyl)amino)acetonitrile

2-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-(methyl)amino)acetonitrile

C

2-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-4-(dimethylamino)butanenitrile

2-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-4-(dimethylamino)butanenitrile

Conditions
ConditionsYield
With 2-Picolinic acid; iron(III) chloride; tert-Butyl peroxybenzoate; 18-crown-6 ether In acetonitrile at 50℃; for 48h;A 6%
B 35%
C 15%
5-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-4-methylene-4,5-dihydro-isoxazol-5-yl]-10,11-dihydro-5H-dibenzo[b,f]azepine
152700-41-9

5-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-4-methylene-4,5-dihydro-isoxazol-5-yl]-10,11-dihydro-5H-dibenzo[b,f]azepine

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

4-Chloromethyl-3-(3,5-dichloro-2,4,6-trimethyl-phenyl)-isoxazole

4-Chloromethyl-3-(3,5-dichloro-2,4,6-trimethyl-phenyl)-isoxazole

C

5-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-isoxazol-(4Z)-ylidenemethyl]-10,11-dihydro-5H-dibenzo[b,f]azepine

5-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-isoxazol-(4Z)-ylidenemethyl]-10,11-dihydro-5H-dibenzo[b,f]azepine

D

4-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-isoxazol-4-ylmethyl]-10,11-dihydro-5H-dibenzo[b,f]azepine

4-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-isoxazol-4-ylmethyl]-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With zinc(II) chloride In toluene for 6h; Heating; Further byproducts given;A 14%
B 3%
C 33%
D 22%
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

desipramine
50-47-5

desipramine

B

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

C

10-Hydroxyimipramine
796-28-1

10-Hydroxyimipramine

Conditions
ConditionsYield
In water Ambient temperature; M. griseo-cyanus (ATCC 1207a); further microbial agents;A 10 mg
B n/a
C n/a
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

desipramine
50-47-5

desipramine

B

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

C

10-Hydroxyimipramine
796-28-1

10-Hydroxyimipramine

D

2-hydroxyimipramine
303-70-8

2-hydroxyimipramine

Conditions
ConditionsYield
In water for 480h; Ambient temperature; C. blakesleeana (ATCC 8688a); further microbial agents; Further byproducts given;A n/a
B n/a
C 30 mg
D 88 mg
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

10-Hydroxyimipramine
796-28-1

10-Hydroxyimipramine

C

2-hydroxyimipramine
303-70-8

2-hydroxyimipramine

D

imipramine N-oxide
6829-98-7

imipramine N-oxide

Conditions
ConditionsYield
In water; N,N-dimethyl-formamide for 480h; Ambient temperature; C. blakesleeana (ATCC 8688a); further microbial agents; Further byproducts given;A n/a
B 30 mg
C 88 mg
D n/a
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

imipramine N-oxide
6829-98-7

imipramine N-oxide

Conditions
ConditionsYield
In water; N,N-dimethyl-formamide for 360h; Ambient temperature; F. oxysporum f. sp. cepae (ATCC 11711); further microbial agents;A 7 mg
B n/a
In water for 312h; Ambient temperature; A. flavipes (ATCC 16795); further microbial agents;A n/a
B 112 mg
5-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-4-methylene-4,5-dihydro-isoxazol-5-yl]-10,11-dihydro-5H-dibenzo[b,f]azepine
152700-41-9

5-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-4-methylene-4,5-dihydro-isoxazol-5-yl]-10,11-dihydro-5H-dibenzo[b,f]azepine

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-isoxazole-4-carbaldehyde

3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-isoxazole-4-carbaldehyde

Conditions
ConditionsYield
With zinc(II) iodide In toluene for 6h; Heating;
5-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-isoxazol-(4Z)-ylidenemethyl]-10,11-dihydro-5H-dibenzo[b,f]azepine

5-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-isoxazol-(4Z)-ylidenemethyl]-10,11-dihydro-5H-dibenzo[b,f]azepine

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-isoxazole-4-carbaldehyde

3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-isoxazole-4-carbaldehyde

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane for 4h; Heating;
dibenzoazepine
256-96-2

dibenzoazepine

o-toluidine
95-53-4

o-toluidine

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
palladium on activated charcoal at 230℃; Rate constant;
2,2'-ethylenedianiline
34124-14-6

2,2'-ethylenedianiline

hydrochloride of salt of 2.2'-diamino-dibenzyl

hydrochloride of salt of 2.2'-diamino-dibenzyl

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
at 265 - 275℃;
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

Dimethyl-propylidene-ammonium

Dimethyl-propylidene-ammonium

Conditions
ConditionsYield
at 280 - 326℃; Kinetics;
5-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-4-methylene-4,5-dihydro-isoxazol-5-yl]-10,11-dihydro-5H-dibenzo[b,f]azepine
152700-41-9

5-[3-(3,5-Dichloro-2,4,6-trimethyl-phenyl)-4-methylene-4,5-dihydro-isoxazol-5-yl]-10,11-dihydro-5H-dibenzo[b,f]azepine

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 33 percent / ZnCl2 / toluene / 6 h / Heating
2: aq. HCl / dioxane / 4 h / Heating
View Scheme
2,2'-diaminostilbene
617-20-9

2,2'-diaminostilbene

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: isoamyl alcohol; sodium
2: 265 - 275 °C
View Scheme
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With peroxidase from horseradish type VI; dihydrogen peroxide at 37℃; for 1h; pH=7; aq. phosphate buffer; Enzymatic reaction;
2,2'-dinitrobibenzyl
16968-19-7

2,2'-dinitrobibenzyl

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogen
2: hydrogenchloride / Heating
View Scheme
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

2,4,6,8-tetrabromoiminodibenzyl
100527-68-2

2,4,6,8-tetrabromoiminodibenzyl

Conditions
ConditionsYield
With N-Bromosuccinimide; silica gel In dichloromethane at 18℃; for 3h;100%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

9-bromophenanthrene
573-17-1

9-bromophenanthrene

N-(9-phenanthryl)iminodibenzyl

N-(9-phenanthryl)iminodibenzyl

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;100%
1-bromo-4-methoxy-benzene
104-92-7

1-bromo-4-methoxy-benzene

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

5-(4-methoxyphenyl)-10,11-dihydro-5H-dibenzo[b,f]azepine
91222-27-4

5-(4-methoxyphenyl)-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;100%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Reagent/catalyst; Inert atmosphere;91%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Solvent; Sealed tube; Inert atmosphere;91%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

allyl bromide
106-95-6

allyl bromide

5-allyl-10,11-dihydro-5H-dibenzoazepine
74074-21-8

5-allyl-10,11-dihydro-5H-dibenzoazepine

Conditions
ConditionsYield
Stage #1: 9,10-dihydrodibenzazepine With sodium hydride In N,N-dimethyl-formamide for 0.333333h; Inert atmosphere;
Stage #2: allyl bromide In N,N-dimethyl-formamide Inert atmosphere;
99%
Stage #1: 9,10-dihydrodibenzazepine With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 0.333333h; Inert atmosphere;
Stage #2: allyl bromide In N,N-dimethyl-formamide; mineral oil at 20℃; for 1h; Inert atmosphere;
92%
68%
With sodium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In dichloromethane; water for 72h;14%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

4-chloromethoxybenzene
623-12-1

4-chloromethoxybenzene

5-(4-methoxyphenyl)-10,11-dihydro-5H-dibenzo[b,f]azepine
91222-27-4

5-(4-methoxyphenyl)-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); 1-methyl-2-(2-(dicyclohexylphosphino)phenyl)-1H-benzoimidazole; sodium t-butanolate In toluene at 20 - 135℃; for 20h; Buchwald-Hartwig reaction; Inert atmosphere;99%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Inert atmosphere;87%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Solvent; Sealed tube; Inert atmosphere;87%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

chlorobenzene
108-90-7

chlorobenzene

10,11-dihydro-N-phenyldibenzazepine
78943-60-9

10,11-dihydro-N-phenyldibenzazepine

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;99%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Inert atmosphere;80%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Solvent; Sealed tube; Inert atmosphere;80%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

dibenzoazepine
256-96-2

dibenzoazepine

Conditions
ConditionsYield
With 1-methyl-2-nitrobenzene; palladium on activated charcoal at 230℃; for 1.5h; Rate constant; Kinetics; Thermodynamic data; var. hydrogen acceptors (also without acceptor); ΔH(excit.), ΔS(excit.); var. temp. and time;98.2%
With oxygen; 2,3-dicyano-5,6-dichloro-p-benzoquinone; sodium nitrite In toluene at 120℃; under 9750.98 Torr; for 8h;24%
Stage #1: 9,10-dihydrodibenzazepine With N-Bromosuccinimide
Stage #2: With pyridine
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

(acetylamino)acetaldehyde dimethyl acetal
62005-48-5

(acetylamino)acetaldehyde dimethyl acetal

N-(2-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethyl)acetamide
1262142-12-0

N-(2-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethyl)acetamide

Conditions
ConditionsYield
With triethylsilane; trifluoroacetic acid In dichloromethane at 20℃; for 2h; Inert atmosphere; chemoselective reaction;98%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

2-methylphenyl bromide
95-46-5

2-methylphenyl bromide

5-(o-tolyl)-10,11-dihydro-5H-dibenzo[b,f]azepine

5-(o-tolyl)-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;98%
With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; tris-(dibenzylideneacetone)dipalladium(0); sodium t-butanolate In toluene at 100℃; for 20h; Inert atmosphere; Sealed tube;81%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

1-Bromonaphthalene
90-11-9

1-Bromonaphthalene

N-(1-naphthyl)iminodibenzyl

N-(1-naphthyl)iminodibenzyl

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;98%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

1-Bromo-4-fluorobenzene
460-00-4

1-Bromo-4-fluorobenzene

N-(4-fluorophenyl)iminodibenzyl

N-(4-fluorophenyl)iminodibenzyl

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;98%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Reagent/catalyst; Inert atmosphere;82%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Solvent; Sealed tube; Inert atmosphere;82%
With nickel(II) oxide; potassium tert-butylate; triphenylphosphine In tetrahydrofuran at 100℃; for 24h; Inert atmosphere; Sealed tube; Green chemistry;73%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

4-bromophenethanol
4654-39-1

4-bromophenethanol

2-(4-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)phenyl)ethan-1-ol

2-(4-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)phenyl)ethan-1-ol

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 80℃; for 16h; Inert atmosphere;98%
2-bromo-1-benzothiophene
5394-13-8

2-bromo-1-benzothiophene

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

N-(2-benzothiophenyl)iminodibenzyl

N-(2-benzothiophenyl)iminodibenzyl

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 80℃; for 16h; Inert atmosphere;98%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

2,6-dimethyl-1-chlorobenzene
6781-98-2

2,6-dimethyl-1-chlorobenzene

N-(2,6-dimethylphenyl)iminodibenzyl

N-(2,6-dimethylphenyl)iminodibenzyl

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;97%
2-bromo-pyridine
109-04-6

2-bromo-pyridine

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

5-(pyridin-2-yl)-10,11-dihydro-5H-dibenzo[b,f]azepine

5-(pyridin-2-yl)-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;97%
With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; tris-(dibenzylideneacetone)dipalladium(0); sodium t-butanolate In toluene at 120℃; for 48h; Inert atmosphere;75%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

hexanoic acid
142-62-1

hexanoic acid

5-hexyl-10,11-dihydro-5H-dibenzo[b,f]azepine hydrochloride

5-hexyl-10,11-dihydro-5H-dibenzo[b,f]azepine hydrochloride

Conditions
ConditionsYield
Stage #1: hexanoic acid With sodium tetrahydroborate In toluene at 0 - 5℃;
Stage #2: 9,10-dihydrodibenzazepine With sodium tetrahydroborate In toluene at 25 - 80℃; for 5h;
Stage #3: With hydrogenchloride In water; isopropyl alcohol
97%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

2,8-dibromo-10,11-dihydro-5H-dibenzo[b,f]azepine
40583-96-8

2,8-dibromo-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With phenyltrimethylammonium tribromide In acetonitrile at 20℃; for 4h; Inert atmosphere;96%
With N-Bromosuccinimide In chloroform at 0 - 20℃; for 1h; Darkness;78%
With N-Bromosuccinimide In dichloromethane; N,N-dimethyl-formamide at 20℃; for 1h;63%
With N-Bromosuccinimide In chloroform at 0 - 25℃; for 2h; Inert atmosphere;41%
With N-Bromosuccinimide; silica gel In dichloromethane at 18℃; for 0.2h; Yield given;

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

10,11-dihydro-N-phenyldibenzazepine
78943-60-9

10,11-dihydro-N-phenyldibenzazepine

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;96%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Solvent; Sealed tube; Inert atmosphere;95%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Catalytic behavior; Reagent/catalyst; Solvent; Temperature; Inert atmosphere;90%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

N-(2-biphenyl)iminodibenzyl

N-(2-biphenyl)iminodibenzyl

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;96%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

9-Bromoanthracene
1564-64-3

9-Bromoanthracene

5-(anthracen-9-yl)-10,11-dihydro-5H-dibenzo[b,f]azepine

5-(anthracen-9-yl)-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;96%
With tris-(dibenzylideneacetone)dipalladium(0); lithium hexamethyldisilazane; ruphos In 1,4-dioxane at 100℃; for 24h; Inert atmosphere; Schlenk technique; Sealed tube;75%
5-bromo-1H-indole
10075-50-0

5-bromo-1H-indole

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

N-(5-indolyl)iminodibenzyl

N-(5-indolyl)iminodibenzyl

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 80℃; for 16h; Inert atmosphere;96%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

chloroacetyl chloride
79-04-9

chloroacetyl chloride

2-chloro-1-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethan-1-one
3534-05-2

2-chloro-1-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethan-1-one

Conditions
ConditionsYield
In toluene at 90℃; for 4h; Inert atmosphere;95%
In toluene for 5h; Heating;53%
In toluene Heating;
With benzene
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

acetic anhydride
108-24-7

acetic anhydride

5-acetyliminodibenzyl
13080-75-6

5-acetyliminodibenzyl

Conditions
ConditionsYield
for 3h; Reflux;95%
With acetic acid at 110℃; for 2h;84%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

para-chlorotoluene
106-43-4

para-chlorotoluene

5-(4-methylphenyl)-10,11-dihydro-5H-dibenzo[b,f]azepine
155162-78-0

5-(4-methylphenyl)-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); 1-methyl-2-(2-(dicyclohexylphosphino)phenyl)-1H-benzoimidazole; sodium t-butanolate In toluene at 20 - 135℃; for 20h; Buchwald-Hartwig reaction; Inert atmosphere;94%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Inert atmosphere;81%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Solvent; Sealed tube; Inert atmosphere;81%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

2-Bromo-m-xylene
576-22-7

2-Bromo-m-xylene

N-(2,6-dimethylphenyl)iminodibenzyl

N-(2,6-dimethylphenyl)iminodibenzyl

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Reagent/catalyst; Inert atmosphere;94%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

o-trifluoromethylphenyl bromide
392-83-6

o-trifluoromethylphenyl bromide

N-[2-(trifluoromethyl)phenyl]iminodibenzyl

N-[2-(trifluoromethyl)phenyl]iminodibenzyl

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;94%
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

5-(cyano)dibenzothiophenium triflate

5-(cyano)dibenzothiophenium triflate

10,11-dihydro-5H-dibenzo[b,f]azepine-5-carbonitrile

10,11-dihydro-5H-dibenzo[b,f]azepine-5-carbonitrile

Conditions
ConditionsYield
With caesium carbonate In dichloromethane at 20℃; for 8h; Inert atmosphere;94%
morpholine
110-91-8

morpholine

formaldehyd
50-00-0

formaldehyd

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

bis(morpholinomethyl)-2,8 dihydro-10,11 5H dibenzoazepine
64097-61-6

bis(morpholinomethyl)-2,8 dihydro-10,11 5H dibenzoazepine

Conditions
ConditionsYield
With acetic acid for 30h; Heating;93%

Iminodibenzyl Chemical Properties

Molecular Structure:

Molecular Formula: C14H13N
Molecular Weight: 195.2597
IUPAC Name: 6,11-Dihydro-5H-benzo[b][1]benzazepine
Synonyms of 5H-Dibenz(b,f)azepine, 10,11-dihydro- (CAS NO.494-19-9): 10,11-Dihydro-5-dibenz(b,f)azepine ; 10,11-Dihydro-5H-dibenz(b,f)azepine ; 10,11-Dihydrodibenz(b,f)azepine ; 2,2'-Iminobibenzyl ; 2,2'-Iminodibenzyl ; 5-20-08-00092 (Beilstein Handbook Reference) ; AI3-39165 ; BRN 0152732 ; EINECS 207-787-1 ; Iminobibenzyl ; Iminodibenzyl ; NSC 72110 ; RP 23669
CAS NO: 494-19-9
Classification Code: Skin / Eye Irritant
Melting point: 105-108 °C
Index of Refraction: 1.602
Molar Refractivity: 61.75 cm3
Molar Volume: 179.8 cm3
Surface Tension: 42.6 dyne/cm
Density: 1.085 g/cm3
Flash Point: 161.3 °C
Enthalpy of Vaporization: 57 kJ/mol
Boiling Point: 327.7 °C at 760 mmHg
Vapour Pressure: 0.000199 mmHg at 25°C

Iminodibenzyl Uses

 5H-Dibenz(b,f)azepine, 10,11-dihydro- (CAS NO.494-19-9) is the materials for pharmaceutical intermediates. It can be used for the production of analgesic anti-spasm drug amide hydrochloride microphone. It is also used in synthetic lubricants, high-temperature antioxidant.

Iminodibenzyl Production

Derived by o-nitrotoluene with condensation, reduction, cyclization .

Iminodibenzyl Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 320mg/kg (320mg/kg)   U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#01352,

Iminodibenzyl Consensus Reports

Reported in EPA TSCA Inventory.

Iminodibenzyl Safety Profile

Poison by intravenous route. An eye irritant. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes:Xi
Risk Statements:
36:  Irritating to the eyes
37:  Irritating to the respiratory system
38:  Irritating to the skin
Safety Statements:
22:  Do not breathe dust
24:  Avoid contact with skin
25:  Avoid contact with eyes
26:  In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
27:  Take off immediately all contaminated clothing28:  After contact with skin, wash immediately with plenty of ... (to be specified by the manufacturer) 
36:  Wear suitable protective clothing 
37:  Wear suitable gloves
39:  Wear eye/face protection

Iminodibenzyl Specification

Stability and Reactivity of 5H-Dibenz(b,f)azepine, 10,11-dihydro- (CAS NO.494-19-9):
Conditions to Avoid:incompatible materials.
Chemical Stability:Stable under normal temperatures and pressures.
Incompatibilities with Other Materials:Strong oxidizing agents.
Hazardous Decomposition Products: irritating and toxic fumes and gases,carbon dioxide,hydrogen bromide,Carbon monoxide,nitrogen oxides.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View